Statement Of Changes In Equity [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	33,687,000 EUR	—	—	—	—	19,934,000 EUR	396,254,000 EUR	41,228,000 EUR	408,647,000 EUR	—	336,633,000 EUR	2,545,000 EUR	340,769,000 EUR	—	33,840,000 EUR	—	32,250,000 EUR	—	—	—	219,759,000 EUR	332,535,000 EUR	31,271,000 EUR	13,690,000 EUR	157,737,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	59,620,000 EUR	59,620,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	116,875,000 EUR	116,875,000 EUR	—	—	—	—	—
Other comprehensive income	—	—	—	18,298,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	17,300,000 EUR	—	—	—	—	—	—
Comprehensive income	—	- EUR	18,298,000 EUR	77,918,000 EUR	59,620,000 EUR	—	—	—	—	- EUR	—	—	—	17,300,000 EUR	—	- EUR	—	- EUR	134,175,000 EUR	116,875,000 EUR	—	—	—	—	—
Issue of equity	—	2,834,000 EUR	—	23,339,000 EUR	—	—	—	—	—	20,505,000 EUR	—	—	—	—	—	749,000 EUR	—	2,752,000 EUR	3,501,000 EUR	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	909,000 EUR	909,000 EUR	—	—	—	—	—	—	—	—	—	1,065,000 EUR	—	—	—	—	1,065,000 EUR	—	—	—	—	—	—